-
Signature
-
Tobi B. Lebowitz, Attorney-in-Fact
-
Issuer symbol
-
VSEC
-
Transactions as of
-
27 Feb 2026
-
Net transactions value
-
-$1,572,072
-
Form type
-
4
-
Filing time
-
03 Mar 2026, 16:33:24 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| CUOMO JOHN A |
CEO and President, Director |
3361 ENTERPRISE WAY, MIRAMAR |
Tobi B. Lebowitz, Attorney-in-Fact |
03 Mar 2026 |
0001613941 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VSEC |
Common Stock, par value $.05 |
Options Exercise |
|
+4,500 |
+3% |
|
152,867 |
28 Feb 2026 |
Direct |
F1, F2 |
| transaction |
VSEC |
Common Stock, par value $.05 |
Award |
$0 |
+13,502 |
+8.8% |
$0.000000 |
166,369 |
28 Feb 2026 |
Direct |
F3 |
| transaction |
VSEC |
Common Stock, par value $.05 |
Tax liability |
$1,572,072 |
-7,083 |
-4.3% |
$221.95 |
159,286 |
02 Mar 2026 |
Direct |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VSEC |
Restricted Stock Units |
Award |
$0 |
+7,861 |
|
$0.000000 |
7,861 |
27 Feb 2026 |
Common Stock |
7,861 |
|
Direct |
F5, F6 |
| transaction |
VSEC |
Restricted Stock Units |
Options Exercise |
$0 |
+4,500 |
+100% |
$0.000000 |
9,002 |
28 Feb 2026 |
Common Stock |
4,500 |
|
Direct |
F2, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: